The tweet was deleted by the author.
But we saved everything 🙂.
CME Group urges investors to hedge their risk and capitalize on industry-specific opportunities as Wall Street starts reporting earnings this season.
The company promotes the use of E-mini S&P Financial Select Sector futures and options for precision in trading. Details are available through a provided link.
CME Group ($302.81) is trading below both the MA-20 ($304.57) and MA-50 ($305.30), which indicates near-term and medium-term downward pressure, but remains well above the MA-200 ($280.44), preserving a longer-term bullish structure. The Ichimoku Kijun level on D1 is $310.89, standing as immediate resistance just above the current price. Near-term support is seen at MA-100 ($289.96), with key support at MA-200 ($280.44). Immediate resistance is at the Kijun ($310.89), and key resistance is at MA-50 ($305.30).
Momentum on D1 is tilted bearish, with MACD producing a strong sell signal and ADX suggesting a weak trend. RSI is moderately bearish at 48.38, and Stoch RSI adds a strong sell bias, while CCI sits neutral, showing no clear momentum extremes. BBP points to overbought conditions but has flipped to seller dominance intraday. The Awesome Oscillator is neutral and not supporting directional conviction. In today's session, CME has dropped 2.5%, extending a weekly loss after opening under pressure. CME is trading down from last week's close of $305.11, a decline of 0.75%, and is positioned at the very bottom of the weekly range. Weekly volatility stands at 3.37%. The tone for this week is a steady decline from the highs and increasing downside bias, which broadly aligns with short-term bearish momentum, despite some oscillators being mixed.
Looking ahead to the next 5–7 trading days, CME is expected to fluctuate between $294 and $314, reflecting typical volatility and anchored near recent lows and resistance. Relative to the 52-week band ($251.90–$329.16), the forecast range trends toward the lower third of the yearly interval. Probability of a price increase is very high (more than 80%) based on bullish signals from W1 RSI, ADX, MACD, and MA-50, making further declines less likely. In the baseline scenario, CME remains rangebound between MA-100 support and Kijun resistance. A bullish outcome would see the price break and hold above $311, opening the path toward the yearly high. If support at $290 is breached, a move toward MA-200 ($280) becomes feasible in a bearish scenario, though upward odds remain dominant for the week.
Previously it was reported that CME Group was maintaining a constructive long-term outlook despite short-term volatility, with analysts expecting stabilization and potential upward movement. The current analysis builds on this view by highlighting a key level to watch for potential momentum shifts that may define the next direction for CME shares.